UWS
RANI icon

Unique Wealth Strategies’s Rani Therapeutics RANI Stock Holding History

Unique Wealth Strategies’s Portfolio RANI Stock Details RANI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-24,600
Closed -$18.1K – 259
2026
Q1 		$18.1K Hold
24,600
– – 0.01% 213
2025
Q4 		$33.2K Buy
+24,600
New +$37.1K 0.01% 209

Other funds holding RANI

CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
TIA
Traphagen Investment Advisors Oradell, New Jersey $1.4B AUM 19.32% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
CSP
Cary Street Partners Richmond, Virginia $4.58B AUM 24% 1-Year Est. Return
EL
EWA LLC Pittsbugh, Pennsylvania $548M AUM 35.14% 1-Year Est. Return

Unique Wealth Strategies's RANI Position: Q2 2026 in Review

Unique Wealth Strategies sold out of Rani Therapeutics (RANI) in Q2 2026, closing a stake of 24,600 shares — an estimated $18.1K sold.

Unique Wealth Strategies first reported a position in RANI in Q4 2025 and held it in 2 quarters. The position peaked at $33.2K in Q4 2025. 5 funds tracked by Wall St. Rank hold RANI as of Q2 2026.

  • Unique Wealth Strategies reported no remaining Rani Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Unique Wealth Strategies sold 24,600 Rani Therapeutics shares in Q2 2026, an estimated $18.1K.
  • Unique Wealth Strategies first reported a position in Rani Therapeutics in Q4 2025 and held it in 2 quarters.
  • Unique Wealth Strategies's Rani Therapeutics position peaked at $33.2K in Q4 2025.
  • 5 funds tracked by Wall St. Rank held Rani Therapeutics as of Q2 2026.

Based on Unique Wealth Strategies's 13F filing for Q2 2026, filed 15 Jul 2026.